UK data regulator fines American Express up to 0.021p per email after opted-out folk spammed 4.1 million times

Bank made $1.4bn in profits alone last quarter


American Express has been fined 0.009 per cent of its annual profits by the Information Commissioner's Office (ICO) after spamming people who opted out of its marketing emails with 4.1 million unwanted messages.

The £90,000 fine was announced today after the British data regulator ruled the US bank had broken the law.

"This is a clear example of a company getting it wrong and now facing the reputational consequences of that error," said ICO head of investigations Andy Curry, recognising the fine was effectively small change for Amex.

"Between 1 June 2018 and 21 May 2019, 4,098,841 of those emails were marketing emails, designed to encourage customers to make purchases on their cards which would benefit Amex financially. It was a deliberate action for financial gain by the organisation. Amex also did not review its marketing model following customer complaints," said the ICO in a statement.

Customers were encouraged to spend £500 on their American Express credit cards in return for a £50 benefit, under the title "award-winning offers just for you".

The bank ignored complaints and when those customers went to the ICO, bankers claimed the spam was "a requirement of its Credit Agreements with customers". This was untrue – and the customers bombarded with spam had already opted out of marketing emails.

Justifying the spamming of its own customers, Amex claimed the spam was internally classified as a service message instead of marketing. Service messages are meant to be used for information about the service – for example, notifications of scheduled downtime or changes in interest rates. Instead Amex sent them unwanted inbox filler advertising new products and services.

The bank told its customers: "We feel that Card Members would be at a disadvantage if they were not aware of these campaigns and promotional periods."

The ICO found that Amex had broken the Privacy and Electronic Communications Regulations 2003, the law on sending marketing emails. The ICO's monetary penalty notice, which stated that Amex acted negligently rather than deliberately, said: "AMEX, as the transmitter or instigator of the direct marketing, is required to ensure that it is acting in compliance with the requirements of Regulation 22 of PECR, and to ensure that valid consent to send those messages had been acquired."

In Amex's case, 49 per cent of its customers had not opted in to receive marketing emails or had explicitly opted out – yet many of these collectively received the millions of messages sent by the bank anyway.

We have attempted to contact American Express for comment and will update this article if we hear back. In Q4 FY2020 alone Amex made $1.4bn in profit.

The maximum fine for a breach of PECR is £500,000, though the regulator indicated it would impose a £90k penalty in a preliminary notice back in February, to which Amex did not object.

The £90k fine equates to 0.021p per nuisance email however it is discounted to £72k if paid by 15 June. This would mean the regulatory cost to Amex of doing business by sending 4.1 million unlawful marketing emails would be about 0.017p per message. Yesterday the ICO priced unlawful emails at 9.5p when it fined a coronavirus track-and-trace company for identical lawbreaking. ®

Similar topics


Other stories you might like

  • Google sours on legacy G Suite freeloaders, demands fee or flee

    Free incarnation of online app package, which became Workplace, is going away

    Google has served eviction notices to its legacy G Suite squatters: the free service will no longer be available in four months and existing users can either pay for a Google Workspace subscription or export their data and take their not particularly valuable businesses elsewhere.

    "If you have the G Suite legacy free edition, you need to upgrade to a paid Google Workspace subscription to keep your services," the company said in a recently revised support document. "The G Suite legacy free edition will no longer be available starting May 1, 2022."

    Continue reading
  • SpaceX Starlink sat streaks now present in nearly a fifth of all astronomical images snapped by Caltech telescope

    Annoying, maybe – but totally ruining this science, maybe not

    SpaceX’s Starlink satellites appear in about a fifth of all images snapped by the Zwicky Transient Facility (ZTF), a camera attached to the Samuel Oschin Telescope in California, which is used by astronomers to study supernovae, gamma ray bursts, asteroids, and suchlike.

    A study led by Przemek Mróz, a former postdoctoral scholar at the California Institute of Technology (Caltech) and now a researcher at the University of Warsaw in Poland, analysed the current and future effects of Starlink satellites on the ZTF. The telescope and camera are housed at the Palomar Observatory, which is operated by Caltech.

    The team of astronomers found 5,301 streaks leftover from the moving satellites in images taken by the instrument between November 2019 and September 2021, according to their paper on the subject, published in the Astrophysical Journal Letters this week.

    Continue reading
  • AI tool finds hundreds of genes related to human motor neuron disease

    Breakthrough could lead to development of drugs to target illness

    A machine-learning algorithm has helped scientists find 690 human genes associated with a higher risk of developing motor neuron disease, according to research published in Cell this week.

    Neuronal cells in the central nervous system and brain break down and die in people with motor neuron disease, like amyotrophic lateral sclerosis (ALS) more commonly known as Lou Gehrig's disease, named after the baseball player who developed it. They lose control over their bodies, and as the disease progresses patients become completely paralyzed. There is currently no verified cure for ALS.

    Motor neuron disease typically affects people in old age and its causes are unknown. Johnathan Cooper-Knock, a clinical lecturer at the University of Sheffield in England and leader of Project MinE, an ambitious effort to perform whole genome sequencing of ALS, believes that understanding how genes affect cellular function could help scientists develop new drugs to treat the disease.

    Continue reading

Biting the hand that feeds IT © 1998–2022